Last updated on May 2020

Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke


Brief description of study

This is a Phase II study to assess the safety and tolerability of DM199 in acute ischemic stroke patients. The study will be randomized, placebo controlled at multiple centers.

Clinical Study Identifier: NCT03290560

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.